Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation
In favor of their outgrowth, cancer cells must resist immune surveillance and edit the immune response. Cancer immunoediting is characterized by fundamental changes in the cellular composition and the inflamma...
Cell Communication and Signaling 2017 15:5
Published on: 19 January 2017